A prospective, open-label, multi-center study to evaluate efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in genotype 1 patients with previous protease inhibitors failure: Interim analysis (the emerald study)

Authors
Category Primary study
JournalHepatology
Year 2017
This article has no abstract
Epistemonikos ID: 125f16eea8d8ecbe5a49d23b90be7b33d4ef5479
First added on: Feb 08, 2025